Partial passive protection with two monoclonal antibodies and frequency offeeding of hyperimmune anti-transmissible gastroenteritis virus (TGEV) serum for protection of three-day-old piglets from a TGEV challenge infection
Rd. Wesley et Rd. Woods, Partial passive protection with two monoclonal antibodies and frequency offeeding of hyperimmune anti-transmissible gastroenteritis virus (TGEV) serum for protection of three-day-old piglets from a TGEV challenge infection, J VET D INV, 13(4), 2001, pp. 290-296
Passive protection experiments were conducted to determine the frequency an
d amounts of hyperimmune antiserum needed to block a transmissible gastroen
teritis virus (TGEV) challenge infection and to identify monoclonal antibod
ies that are partially protective against TGEV. Hyperimmune antiserum or mo
noclonal antibodies were added to milk at each feeding or at selected feedi
ngs when the amount of antiserum was reduced. Three-day-old piglets were ch
allenged with virulent virus that had been preincubated with antiserum or m
onoclonal antibodies. The results indicated that supplementing antiserum ev
ery other day was not efficacious for protection. Supplementing even small
quantities of hyperimmune antiserum (0.5 ml) at least once a day in most ca
ses was sufficient for piglet survival but did not prevent morbidity, Incre
asing the amount (>2 ml) and providing, antiserum 3 times/day completely bl
ocked the TGEV challenge infection. Two monoclonal, antibodies were discove
red that also provided passive protection for baby pigs. One monoclonal ant
ibody, 5G1, had a high neutralizing titer, and the other, 6C4, was more eff
ective in neutralizing and binding to virulent TGEV than to attenuated TGEV
s. Both of these monoclonal antibodies were partially effective as suppleme
nts in milk for passive protection. Furthermore, these monoclonal antibodie
s were useful for boosting the efficacy of TGEV-neutralizing, colostrum, wh
ich by itself was ineffective. These results show that other antigenic site
s, different from the 4-well characterized epitopes on the S glycoprotein o
f TGEV, also are important for passive protection.